ANG Life Sciences India H1FY22 consolidated PAT zooms to Rs. 33.77 crore
News

ANG Life Sciences India H1FY22 consolidated PAT zooms to Rs. 33.77 crore

ANG Lifesciences India Limited has reported financial results for the period ended September 30, 2021

  • By IPP Bureau | October 26, 2021

Financial Results (H1 FY21-22)

The company has reported net sales of Rs.215.5458 crore during the 6 months period ended September 30, 2021 as compared to Rs.68.3789 crore during the period ended March 31, 2021.

The company has posted net profit of Rs.33.7779 crore for the 6 months period ended September 30, 2021 as against Rs.1.5254 crore for the 6 months period ended March 31, 2021.

Financial Results (H1 FY21-22) - YoY Comparison

The company has reported net sales of Rs.215.5458 crore during the 6 months period ended September 30, 2021 as compared to Rs.86.5559 crores during the 6 months period ended September 30, 2020.

The company has posted net profit of Rs.33.7779 crores for the 6 months period ended September 30, 2021 as against Rs.5.5021 crores for the 6 months period ended September 30, 2020.

Upcoming E-conference

Other Related stories

Startup

Digitization